Metabolomics means indentification and quantification of cellular metabolites with the help of refined analytical technologies. Metabolomics involves usage of multi-variant and statistical methods for understanding data as well as information mining. Metabolomics gives a direct functional information of the physiological state of an organism and is used in bridging the gap between phenotype and genotype by providing a total and complete view of the functioning of a cell along with identification of novel alterations in certain metabolites. Various advanced analytical technologies are introduced and are employed to examine metabolites in different tissues, organisms or fluids. These small molecules and their interactions in the respective biological system are known as metabolomes. Since metabolomics involves the study of products of metabolism and substrates, it is generally affected by environmental and genetic factors. Metabolomics find a wide range of applications including determination of gene functioning, phenotyping of genetically modified plants and respective equivalence testing and monitoring responses to abiotic and biotic stress. Metabolomics is used as an important life science tool since it is a comparatively precise and fast technique that can be either applied with a particular focus or in an overall manner to gain knowledge on various biological systems. Metabolomics find importance in genomic studies since it controls the functions of unknown genes since the changes associated with small molecules concentrations are closely attached with the detected phenotype.
The global metabolomics market is majorly driven due to increasing demand for personalized medicines. Moreover, increasing government funding and organizational initiatives, especially in Europe and North America is a key factor fueling the growth of metabolomics market. Increasing necessity for improved research and development facilities along with rising investments in toxicology technologies across pharmaceutical and biotechnology sectors are some key factors propelling the growth of global metabolomics market. Since personalized health care facilities facilitates in providing information to detect the onset of diseases at an earlier stage, it prevents the progression of disease as well as increases the effectiveness of healthcare system by refining the overall availability, quality and affordability, thus driving the global metabolomics market. Increasing prevalence of chronic degenerative diseases such as neurodegenerative diseases, cardiovascular diseases, cancer etc. is a key opportunities for the growth of metabolomics market. Also, growing unmet medical demands is in turn creating the demand for personalized medication facilities across the globe, thus driving the market for metabolomics. However, lack of standardized protocols and data complexity are some major factors hindering the growth of global metabolomics market. Moreover, shortage of skilled personnel in the field of metabolomics and unavailability of complete metabolite libraries are some important factors hampering the market growth.
The global metabolomics market can be segmented on the basis of technique, indication, application and geography. On the basis of technique, the global metabolomics market can be segmented into separation techniques and detection techniques. Separation techniques segment can be further sub-segmented into gas chromatography, ultra performance liquid chromatography, capillary electrophoresis, and high performance liquid chromatography. The detection techniques segment is further sub-segmented into mass spectrometry, surface based mass analysis and nuclear magnetic resource spectroscopy. On the basis of application, the global metabolomics market can be segmented into drug discovery, toxicology testing, nutrigenomics, biomarker discovery and others. On the basis of indication the global metabolomics market can be segmented into cardiology, neurology, oncology and others. On the basis of geography, the global metabolomics market can be segmented into North America, Latin America, Europe, Middle East & Africa and Asia-Pacific.
Key players involved in the manufacture of metabolomic devices include Thermo Fisher Scientific Inc., Biocrates Life Sciences AG, Human Metabolome Technologies Inc., Metabolon Inc., Bruker Corporation, LECO Corporation, Waters Corporation, Agilent Technologies, Bio-Rad laboratories Inc., Shimadzu Corporation and others.
Market by Technique
· Separation techniques
o Gas chromatography
o Ultra performance liquid chromatography
o Capillary electrophoresis
o High performance liquid chromatography
· Detection techniques
o Mass spectrometry
o Surface based mass analysis
o Nuclear magnetic resource spectroscopy
Market by Indication
Market by Application
· Drug discovery
· Toxicology testing
· Biomarker discovery
Market by Geography
· North America
o Rest of Europe
o Rest of Asia-Pacific
· Latin America
o Rest of Latin America
· Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o Rest of MEA
Introduction The global women’s health diagnostics market size is anticipated to hit around USD 77.2 billion by 2026, this market is anticipated to grow with 7.3% CAGR during the forecast time period. Increasing occurrence of infectious diseases, for instance, urinary tract infection and hepatitis, among women is expected to boost the women’s health dia
Introduction The global Medical equipment rental market size is expected to reach a value of USD 65.4 billion by 2026, this market is anticipated to grow with 4.5% CAGR during the forecast time period. Growing base of geriatric and handicapped populace combined with rising requirement for home medicinal services items is pushing the market. Also, growing base of ge
Introduction The global Healthcare information systems market size is estimated to reach around USD 170.2 billion by 2026, this market is anticipated to grow with 7.8% CAGR during the forecast time period. Increase in technology penetration in healthcare sector drives the need for the healthcare information system market.
Introduction The global beauty and personal care products market size is estimated to reach around USD 717.6 billion by 2026, this market is anticipated to grow with 7.2% CAGR during the forecast time period. Market Dynamics Rising adoption and execution of AR in the magnific
Introduction The global medical device outsourcing market size in terms of revenue is expected to reach USD 193.6 billion in 2026. The global medical device outsourcing market is expected to experience a CAGR of 10.7% during the forecast period. Growing demand for medical devices tied with growing trend of off-shoring is expected to drive the market during the fore
Introduction The global Hi-tech medical devices market size estimated to reach around USD 198.4 billion by 2026, this market is anticipated to grow with 30.4% CAGR during the forecast time period. Worker health programs alongside upgraded exactness, style, and toughness of gadgets are among the essential development stimulants for the market.